Sushil Kumar Mukherjee

Affiliations: 
1945-1957 University of Calcutta, Kolkata, West Bengal, India 
 1957-1960 University of Indonesia, Paris, Jawa Barat, Indonesia 
 1960-1961 Indian Association for the Cultivation of Science 
 1961-1965 University of Kalyani, Kolkata, West Bengal, India 
 1965-1968 University of Calcutta, Kolkata, West Bengal, India 
 1968-1976 University of Kalyani, Kolkata, West Bengal, India 
 1976-1977 Bose Institute, Kolkata, West Bengal, India 
 1977-1978 University of Calcutta, Kolkata, West Bengal, India 
Area:
Physical chemistry, soil science
Website:
http://www.insaindia.res.in/BM/BM32_0708.pdf
Google:
"Sushil Kumar Mukherjee"
Bio:

(1914 - 2006)

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leong DP, Fradet V, Shayegan B, et al. (2020) Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study. The Journal of Urology. 101097JU000000000000
Kapoor A, Wong NC, Wang Y, et al. (2019) Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases. Asian Journal of Andrology
Donovan E, Dhesy-Thind S, Mukherjee S, et al. (2019) Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists. The Breast Journal
Mackett K, Dhesy-Thind S, Donovan EK, et al. (2019) A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy. Clinica Chimica Acta; International Journal of Clinical Chemistry
Major P, Lacombe L, Fradet Y, et al. (2012) Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients Cancer Research. 72: A16-A16
Figueredo A, Coombes ME, Mukherjee S. (2008) Adjuvant therapy for completely resected stage II colon cancer. The Cochrane Database of Systematic Reviews. CD005390
See more...